Ernst Heinen

from Kansas City, KS

Get Report

Ernst Heinen Phones & Addresses

Kansas City, KS

Business Records

Name / Title

Company / Classification

Phones & Addresses

Ernst Heinen
Chief development officer, Chief Development Officer , Top Executive

Aratana Therapeutics Inc.
Pharmaceuticals · Animal Services · Nonclassifiable Establishments · Pharmaceutical Preparations

1901 Olathe Blvd, Kansas City, KS 66103
(913) 951-2132

Ernst Heinen

KANSAS CITY AREA DEVELOPMENT COUNCIL
Administrative General Economic Programs · Commercial Nonphysical Research

30 W Pershing Rd SUITE 200, Kansas City, MO 64108
(816) 221-2121, (816) 842-2865, (888) 995-2232

Publications

Us Patents

Compositions And Methods For Chronic Use Of A Weight-Gaining Compound

View page

US Patent:

20160213735, Jul 28, 2016

Filed:

Jan 27, 2016

Appl. No.:

15/007525

Inventors:

- Kansas City KS, US
Marie-Paul Lachaud - Paris, FR
Bill Zollers - Kansas City KS, US
Ernst Heinen - Kansas City KS, US

International Classification:

A61K 38/05
A61K 9/107
G01N 33/74
A61K 9/00

Abstract:

Provided herein is a method of treating weight loss in one or more companion animals or livestock. The method can provide administering a therapeutically effective amount of a capromorelin-containing composition to a companion animal or livestock in need thereof for a period of at least 30 days. Optionally, one or more flavoring agents or flavor-masking agents can be added to the capromorelin-containing composition to enhance or mask the flavoring of the composition for the companion animal or livestock.

Compositions And Methods Of Use Of An Inappetance-Controlling Compound

View page

US Patent:

20140088139, Mar 27, 2014

Filed:

Sep 27, 2013

Appl. No.:

14/039114

Inventors:

Bill ZOLLERS - Kansas City KS, US
Linda RHODES - Kansas City KS, US
Ernst HEINEN - Kansas City KS, US
Gopinath DEVARAJ - Auckland, NZ

Assignee:

Aratana Therapeutics, Inc. - Kansas City KS

International Classification:

A61K 31/437
A61K 45/06

US Classification:

514303

Abstract:

The invention provides for a method of treating inappetance-induced weight loss in one or more companion animals or livestock. The method provides for administering a therapeutically effective amount of a capromorelin-containing composition to the companion animal or livestock. Optionally, one or more flavoring agents or flavor-masking agents can be added to the capromorelin-containing composition to enhance or mask the flavoring of the composition for the companion animal or livestock.